These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1366721)

  • 1. Viral contamination of monoclonal antibody preparations: potential problems and possible solutions.
    Harbour C; Woodhouse G
    Cytotechnology; 1990 Jul; 4(1):3-12. PubMed ID: 1366721
    [No Abstract]   [Full Text] [Related]  

  • 2. Virological aspects of the quality control of human monoclonal antibodies.
    Minor P
    Dev Biol Stand; 1991; 75():233-6. PubMed ID: 1794626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration.
    Maerz H; Hahn SO; Maassen A; Meisel H; Roggenbuck D; Sato T; Tanzmann H; Emmrich F; Marx U
    Nat Biotechnol; 1996 May; 14(5):651-2. PubMed ID: 9630961
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of viral clearance unit operations for monoclonal antibodies.
    Miesegaes G; Lute S; Brorson K
    Biotechnol Bioeng; 2010 Jun; 106(2):238-46. PubMed ID: 20073086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hazards of retroviruses associated with monoclonal antibody production.
    Thornton DH; Nicholas RA
    Dev Biol Stand; 1984; 57():9-12. PubMed ID: 6526154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of viral particles in hybridoma clones secreting monoclonal antibodies.
    Bartal AH; Feit C; Erlandson R; Hirshaut Y
    N Engl J Med; 1982 Jun; 306(23):1423. PubMed ID: 7078583
    [No Abstract]   [Full Text] [Related]  

  • 7. Viral contamination of therapeutic proteins: a challenge for downstream processing.
    Harbour C; Woodhouse G; Barford JP; Spencer J; MacLeod AJ
    Aust J Biotechnol; 1991 Apr; 5(2):81-6. PubMed ID: 1369328
    [No Abstract]   [Full Text] [Related]  

  • 8. Clearance of murine leukaemia virus from monoclonal antibody solution by a hydrophilic PVDF microporous membrane filter.
    Aranha-Creado H; Peterson J; Huang PY
    Biologicals; 1998 Jun; 26(2):167-72. PubMed ID: 9811524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification process monitoring in monoclonal antibody preparation: contamination with viruses, DNA and peptide growth factors.
    ter Avest AR; van Zoelen EJ; Spijkers IE; Osterhaus AD; van Steenis G; van Kreyl CF
    Biologicals; 1992 Sep; 20(3):177-86. PubMed ID: 1457104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody purification guide: Part 1.
    Grandics P
    Am Biotechnol Lab; 1994 May; 12(6):58-62. PubMed ID: 7764751
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isolation of monoclonal antibodies to influenza viruses].
    Iamnikova SS; Kurochkin SN; Gnuchev NV; Iurkif VA; Severin ES
    Vopr Virusol; 1983; 28(1):21-4. PubMed ID: 6845713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of therapeutic proteins.
    Bonnerjea J
    Methods Mol Biol; 2004; 244():455-62. PubMed ID: 14970579
    [No Abstract]   [Full Text] [Related]  

  • 13. Effective use of gamma irradiation for pathogen inactivation of monoclonal antibody preparations.
    Grieb T; Forng RY; Brown R; Owolabi T; Maddox E; McBain A; Drohan WN; Mann DM; Burgess WH
    Biologicals; 2002 Sep; 30(3):207-16. PubMed ID: 12217345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Note for guidance. Production and quality control of human monoclonal antibodies. Committee for Proprietary Medicinal Products: Ad hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
    Biologicals; 1991 Apr; 19(2):133-8. PubMed ID: 1888492
    [No Abstract]   [Full Text] [Related]  

  • 15. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses.
    Nicklas W; Kraft V; Meyer B
    Lab Anim Sci; 1993 Aug; 43(4):296-300. PubMed ID: 8231085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
    Farshid M; Taffs RE; Scott D; Asher DM; Brorson K
    Curr Opin Biotechnol; 2005 Oct; 16(5):561-7. PubMed ID: 16095899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus filtration of high-concentration monoclonal antibody solutions.
    Marques BF; Roush DJ; Göklen KE
    Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian cells and their contaminants.
    Minor PD
    Dev Biol Stand; 1996; 88():25-9. PubMed ID: 9119147
    [No Abstract]   [Full Text] [Related]  

  • 19. Is rodent virus contamination of monoclonal antibody preparations for use in human therapy a hazard?
    Carthew P
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():963-74. PubMed ID: 3011978
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral clearance using disposable systems in monoclonal antibody commercial downstream processing.
    Zhou JX; Solamo F; Hong T; Shearer M; Tressel T
    Biotechnol Bioeng; 2008 Jun; 100(3):488-96. PubMed ID: 18438883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.